Structure of Mobocertinib Capsules
Mobocertinib capsule (Mobocertinib) is a new type of targeted therapy drug, mainly used to treat EGFR (epidermal growth factor receptor) mutant non-small cell lung cancer (NSCLC). It is a third-generation EGFR inhibitor specifically designed to target lung cancer patients with the EGFR T790M mutation, a common drug-resistant mutation in lung cancer treatment.
The main mechanism of action of mobosetinib is to prevent the growth and spread of cancer cells by inhibiting the activity ofEGFR mutants. EGFR is an important signaling pathway protein involved in the regulation of cell growth and division. EGFRMutantNSCLC The EGFR gene mutation will cause this signaling pathway to be abnormally active and promote the abnormal growth of cancer cells. Mobosetinib controls the proliferation of cancer cells by specifically binding to EGFR mutants and inhibiting their activity.

Mobosetinib is usually available in oral capsules for patient convenience. In clinical trials, mobosetinib has shown significant efficacy in patients with EGFR T790M mutation-positive NSCLC. It extends progression-free survival (PFS), improves overall response rate (ORR), and is expected to have a positive impact on overall survival (OS).
It should be noted that the structural information of drugs is usually strictly protected by patents, so illegal or unauthorized use of this information may involve legal issues. If you require more detailed information about mobosertinib, including its molecular structure, I recommend that you consult the relevant medical literature, package inserts, or consult a medical professional or pharmacist.
Mobotinib is currently on the market in China, but it is not included in medical insurance. Patients need to pay for it in full, so the price is very high. Please consult the local hospital pharmacy for specific prices. Other versions include the Hong Kong version of the original drug Mobotinib, which costs around 7,000 to 8,000 yuan. The generic drug of Mobotinib is mainly a Laotian generic drug. The price is about three to four thousand yuan, which is nearly half cheaper than the original drug. The ingredients of the original drug and the generic drug are the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)